Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
IMVT:NASDAQ
Immunovant Inc
$28.58
-1.14%
(-0.33) 1D
$28.58
0.00% (0.00)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMVT...
Open
$28.96
High
$29.18
Low
$28.29
Mkt. cap
5.82B
Avg. vol.
1.49M
Volume
1.36M
52-wk high
$29.48
52-wk low
$13.36
EPS
-$2.68
Beta
0.67
Shares outstanding
203.53M
No. of employees
362
News stories
From sources across the web
About Immunovant Inc
CEO-
Employees362
Founded2018
Headquarters-
SectorBiotechnology
Last report
Feb 6, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-0.61/ (-0.69 est.)USD
+11.86%beat
Revenue / Estimate
-/ (0.00 est.)USD
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
93.65M
101.20M
114.25M
98.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.17M
26.02M
17.51M
15.44M
Operating expense
113.82M
127.22M
131.76M
114.36M
Total operating expenses
113.82M
127.22M
131.76M
114.36M
Operating income
-113.82M
-127.22M
-131.76M
-114.36M
Other non operating income
1.07M
1.19M
250.00K
-54.00K
EBT including unusual items
-105.87M
-119.70M
-125.91M
-109.08M
EBT excluding unusual items
-105.87M
-119.70M
-125.91M
-109.08M
Income tax expense
583.00K
913.00K
594.00K
1.55M
Effective tax rate
-0.55%
-0.76%
-0.47%
-1.42%
Other operating expenses
-
-
-
-
Net income
-106.45M
-120.61M
-126.50M
-110.64M
Net profit margin
-
-
-
-
Earnings per share
-0.64
-0.71
-0.65
-0.54
Interest and investment income
6.89M
6.34M
5.60M
5.33M
Interest expense
-
-
-
-
Net interest expenses
6.89M
6.34M
5.60M
5.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
-113.72M
-127.12M
-131.66M
-114.26M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more